CS
GBIO

Credit Suisse’s Generation Bio GBIO Stock Holding History

Credit Suisse’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,050
Closed -$120K – 3445
2022
Q4 		$120K Sell
3,050
-33
-1% -$1.73K ﹤0.01% 3299
2022
Q3 		$164K Buy
3,083
+22
+0.7% +$1.38K ﹤0.01% 3312
2022
Q2 		$201K Buy
3,061
+414
+16% +$27.1K ﹤0.01% 3326
2022
Q1 		$195K Buy
2,647
+152
+6% +$8.81K ﹤0.01% 3378
2021
Q4 		$177K Buy
2,495
+84
+3% +$14.7K ﹤0.01% 4302
2021
Q3 		$605K Buy
2,411
+139
+6% +$33.3K ﹤0.01% 3691
2021
Q2 		$611K Buy
2,272
+17
+0.8% +$5.08K ﹤0.01% 3717
2021
Q1 		$641K Buy
2,255
+150
+7% +$48K ﹤0.01% 3605
2020
Q4 		$597K Buy
+2,105
New +$676K ﹤0.01% 3697

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Credit Suisse's GBIO Position: Q1 2023 in Review

Credit Suisse sold out of Generation Bio (GBIO) in Q1 2023, closing a stake of 3,050 shares — an estimated $120K sold.

Credit Suisse first reported a position in GBIO in Q4 2020 and held it in 9 quarters. The position peaked at $641K in Q1 2021. 83 funds tracked by Wall St. Rank hold GBIO as of Q1 2023.

  • Credit Suisse reported no remaining Generation Bio position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 3,050 Generation Bio shares in Q1 2023, an estimated $120K.
  • Credit Suisse first reported a position in Generation Bio in Q4 2020 and held it in 9 quarters.
  • Credit Suisse's Generation Bio position peaked at $641K in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Generation Bio as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.